Hruszkewycz V, Holtrop P C, Batton D G, Morden R S, Gibson P, Band J D
Department of Epidemiology, William Beaumont Hospital, Royal Oak, Michigan 48073.
Infect Control Hosp Epidemiol. 1991 Sep;12(9):544-8. doi: 10.1086/646407.
To assess the incidence and spectrum of complications associated with central venous catheter (CVC) placement in the critically ill infant.
A prospective study of all babies hospitalized in a neonatal intensive care unit (NICU) from January 1989 to December 1989. Potential risk factors associated with infection were evaluated by a case-control comparison.
Conducted at a university-affiliated, tertiary care community hospital.
Neonates requiring intensive care and a central venous catheter. Controls consisted of noninfected babies.
Of 263 critically ill neonates, only 13 (4.9%) required a CVC insertion. Seventeen CVCs were placed in these 13 neonates for a total duration of 600 days (median, 32 days/cannula). Fifteen (88%) of these cannulas had one or more complications during its catheter life including dislodgement or leakage (53%), occlusion or thrombosis (47%), infections (29%), or minor bleeding (12%). Five babies (29%) developed 6 episodes of bloodstream infection including 3 sporadic cases due to Staphylococcus epidermidis and a cluster of fungemia due to Malassezia furfur associated with lipid emulsion therapy. Infants with a CVC-associated infection were a younger gestational age (24 weeks versus 32 weeks, p = .04) and weighed less at birth (580 g versus 1285 g, p = .02). The overall rate of bloodstream infection was one episode per 100 days of catheter use.
CVCs may be lifesaving to a critically ill neonate, but complications occur frequently. Use must be restricted to infants in whom alternate delivery routes of intravenous therapy or support are otherwise unavailable.
评估危重症婴儿中心静脉导管(CVC)置入相关并发症的发生率及范围。
对1989年1月至1989年12月在新生儿重症监护病房(NICU)住院的所有婴儿进行前瞻性研究。通过病例对照比较评估与感染相关的潜在危险因素。
在一所大学附属的三级医疗社区医院进行。
需要重症监护及中心静脉导管的新生儿。对照组为未感染婴儿。
263例危重症新生儿中,仅13例(4.9%)需要置入CVC。这13例新生儿共置入17根CVC,总时长600天(中位数,每根导管32天)。其中15根(88%)导管在其留置期间出现一种或多种并发症,包括移位或渗漏(53%)、堵塞或血栓形成(47%)、感染(29%)或轻微出血(12%)。5例婴儿(29%)发生6次血流感染,包括3例因表皮葡萄球菌引起的散发病例以及1例因糠秕马拉色菌引起的与脂质乳剂治疗相关的真菌血症聚集性病例。发生CVC相关感染的婴儿胎龄更小(24周对32周,p = 0.04),出生体重更轻(580 g对1285 g,p = 0.02)。血流感染的总体发生率为每使用100天导管发生1次。
CVC对危重症新生儿可能是救命的,但并发症频繁发生。必须仅限于无法采用其他静脉治疗或支持给药途径的婴儿使用。